GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,010 | -615 | -3,700 | -2,562 | -2,585 |
| Depreciation Amortization | 49 | 32 | 307 | 326 | 266 |
| Other Working Capital | 1,689 | 103 | 604 | 657 | 224 |
| Other Operating Activity | 777 | 288 | 1,826 | 940 | 1,555 |
| Operating Cash Flow | $-495 | $-192 | $-963 | $-639 | $-540 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 408 | 220 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 977 | 621 | 621 |
| Debt Repayment | N/A | N/A | N/A | -50 | -50 |
| Common Stock Issued | N/A | N/A | 24 | 14 | 4 |
| Financing Cash Flow | $408 | $220 | $1,001 | $585 | $575 |
| Beginning Cash Position | 92 | 92 | 54 | 54 | 54 |
| End Cash Position | 5 | 120 | 92 | N/A | 89 |
| Net Cash Flow | $-87 | $28 | $38 | $-54 | $35 |
| Free Cash Flow | |||||
| Operating Cash Flow | -495 | -192 | -963 | -639 | -540 |
| Free Cash Flow | -495 | -192 | -963 | -639 | -540 |